Leadership and Team
Viritis Team
Viritis is led by a multidisciplinary team with deep experience in biotechnology, clinical development, & venture building

Amit Turman
Technological entrepreneur with 12 years of experience leading startups from ideation to fundraising. He has managed startup accelerators, mentored 400+ companies, and brings expertise in growth strategy, capital raising, and cross-functional team leadership. His background in biotechnology and deep knowledge of healthcare and innovation enable him to bridge science, clinical practice, and business.

Dr. Amit Philosoph
Molecular geneticist with expertise in molecular virology, genetic engineering, bioinformatics, and biotechnology innovation. With a PhD from the Hebrew university, clinical genetics certification, and leadership experience in advanced genome editing research at the Weizmann Institute. Amit brings a unique combination of cutting-edge research and clinical genomics expertise

Aharon Wistoch
A former Israeli Treasury manager with experience in two major financial exits. He brings expertise in capital markets, financial management, and business development, and has led multi-billion-dollar financial programs. A co-founder of previous startups, he specializes in strategic planning, scaling businesses, and fundraising for biotechnology ventures.

Dr. Emiliano Cohen
Ph.D. in Medical Neurobiology and a Master’s in Genetics from the Hebrew University. Expert in genetics and bioinformatics with 15+ years of experience in genomic analysis, essential sequence identification, and clinical exome analysis. Skilled in bacterial genomes, viruses, diverse model organisms, and data-driven research to accelerate genetic discoveries.

Dr. Sharon Navon
Ph.D. in Biochemistry and Molecular Biology and an MBA (Big Data & Business Intelligence track) from the Technion. CEO of a startup developing an innovative topical treatment for psoriasis. Experienced organic chemist with expertise in peptide synthesis, formulation, and product development, combining scientific knowledge and strategic leadership to drive pharmaceutical innovation.